DOI: http://dx.doi.org/10.18203/2319-2003.ijbcp20191103

Drug utilization study and adverse drug reactions of oral anti diabetics among type 2 diabetes mellitus patients in tertiary care hospital

Sahana M. Mogali, Aruna Bhushan, Jagadishchandra S. Ratnakar

Abstract


Background: The aim was to evaluate the drug utilization pattern of oral antidiabetic drugs in type 2 diabetes mellitus outpatients and monitor adverse drug reactions (ADRs) associated with oral antidiabetic drugs.

Methods: A retrospective observational study was carried out by collecting the data of type 2 diabetes mellitus patients visiting outpatient department of noncommunicable disease clinic of a tertiary care hospital for a period of one year. The data of demographic, drug utilization pattern and adverse drug reactions of patients on oral antidiabetic drugs was collected and entered in a proforma.

Results: Total number of patients in this study were 39 out of which 21 (53.85%) patients were females and 18 (46.15%) patients were males. Majority of patients were in the age group 51-70 years (66.6%). Metformin was the most commonly prescribed drug 76.9% followed by Glibenclamide 17.9%. About 7.7% of patients who were taking oral antidiabetic drugs later switched over to insulin as their blood glucose levels were not controlled. Out of 18 (46.15%) patients, hypertension (38.5%) was the most common comorbid condition and a concomitant drug was prescribed was amlodipine 25.6%. Among all the adverse drug reactions observed, diarrhoea was the most common adverse drug reaction reported 76.9%.

Conclusions: Metformin was the most commonly used oral antidiabetic drug. Diarrhoea was the common adverse drug reaction reported.

Keywords


Adverse drug reactions, Drug utilisation, Oral antidiabetic drugs

Full Text:

PDF

References


Fauci AS, Braunwald E, Kasper DL, Hauser SL, Longo DL, Longo DL, et al. In: Alvin C Powers. Diabetes mellitus: diagnosis, classification, and pathophysiology. Harrison’s Principles of Internal Medicine. 19th ed. USA: McGraw Hill; 2017:2398-2407.

King H, Aubert RE, Herman WH. Global burden of diabetes, 1995-2025: prevalence, numerical estimates and projections. Diabetes care. 1998;21(9):1414-31.

Adhikari AK, Vidyasagar G, Rathore DS, Balaram G, Bhakti G. Drug utilization review of antidiabetic drugs in patients of a tertiary care hospital of India. Indian J Hosp Pharm. 2011;48(2):32-4.

Alex SM, Srelekshmi BS, Smitha S, Jiji KN, Menon AS, Uma Devi P. Drug utilization pattern of antidiabetic drugs among diabetic outpatients in tertiary care hospital. Asian J Pharm Clin Res. 2015;8(2):144-6.

Upadhyay DK, Palaian S, Ravi Shankar P, Mishra P, Sah AK. Prescribing pattern in diabetic outpatients in tertiary care teaching hospital in Nepal. J Clin Diagn Res. 2007;3:248-55.

Vengurlekar S, Shukla P, Patidar P, Bafaa R, Jain S. Prescribing pattern of antidiabetic drugs in Indore city hospital. Indian J Pharm Sci. 2008;70(5):637-40.

Dare DJ, Dikshit RK, Gandhi AM. Utilization of some newer oral antidiabetic agents in a tertiary care hospital. Natl J Physiol Pharm Pharmacol. 2012;2(2):146-51.

Kannan, Arshad, Kumar S. A study on drug utilization of oral hypoglycemic agents in type-2 diabetic patients. Asian J Pharm Clin Res. 2011;4:60-4.

Patel B, Oza B, Patel KP, Malhotra SD, Patel VJ. Pattern of antidiabetic drugs use in type 2 diabetic patients in a medicine outpatient clinic of a tertiary care teaching hospital. Int J Basic Clin Pharmacol. 2013;2:485-91.

Sivasankari V, Manivannan E, Priyadarsini SP. Drug utilization pattern of anti-diabetic drugs in a rural area of Tamil Nadu, South India - A prospective, observational study. Int J Pharm Bio Sci. 2013;4:514-9.

Agarwal R, Rath B, Saha K, Mohaptra S. Drug utilization pattern of antidiabetic agents in a tertiary care hospital of western Odisha, India. Int J Basic Clin Pharmacol. 2016;5(5):2222-6.

Thiyagu R, Arulmani R, Narmadha T, Ramlakshami S, Siraj ST. Drug Use Pattern Study of Antidiabetics in Outpatient Setting of a Secondary Care Hospital. Indian J Hosp Pharm. 2008;45(6):176-9.

Jenny L, Arifulla M, Sreedharan J, Muttappallymyalil J, Das R. Age and gender-based utilization pattern of antidiabetic drugs in Ajman, UAE. Malay J Pharm Sci. 2012;10(1):79-85.

John LJ, Arifulla M, Sreedharan J, Muttappallymyalil J, Das R, John J, et al. Age and gender-based utilization pattern of antidiabetic drugs in Ajman, United Arab Emirates. Malay J Pharm Sci. 2012;10:79-85.

Alam MS, Aqil M, Qadry SA, Kapur P, Pillai KK. Utilization pattern of oral hypoglycemic agents for diabetes mellitus type 2 patients attending out-patient department at a University hospital in New Delhi. Pharmacol Pharm. 2014;5:636-45.

Cheung CY, Tso AW, Cheung BM, Xu A, Ong KL, Law LS, et al. Genetic variants associated with persistent central obesity and the metabolic syndrome in a 12-year longitudinal study. Eur J Endocrinol. 2011 Mar 1;164(3):381-8.

Okayasu S, Kitaichi K, Hori A, Suwa T, Horikawa Y, Yamamoto M et al. The evaluation of risk factors associated with adverse drug reactions by metformin in type 2 diabetes mellitus. Bio Pharm Bull 2012;35(6):933-7.